Navigation Links
WaferGen Announces General Availability of Quick-Turnaround SmartChip Custom Panels
Date:1/10/2011

FREMONT, Calif., Jan. 10, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced general availability of its Quick-Turnaround SmartChip Custom Panels to enable validation studies of specific genes of interest through customization of high-throughput, real-time PCR SmartChip assay panels -- all on a Quick-Turnaround basis.

Using the SmartChip Custom Panels, WaferGen can now offer researchers -- on a Quick Turnaround basis -- their own application-specific real-time PCR assay panel.  Customers can choose from WaferGen's existing library of assays, or have WaferGen develop a panel for them. The WaferGen scientific team will design, optimize, and deliver SmartChip Custom Panels with tens to hundreds of assays repeated across the chip.  Custom panels allow customers to save time and money on real-time PCR validation studies compared to traditional methods by enabling hundreds of samples at a cost of $10s to $100s per sample in a single experiment.  The Quick-Turnaround SmartChip Custom Panels become a valuable tool in enabling researchers to validate biomarkers coming from genome-wide Next Generation Sequencing (NGS) discovery programs.

"We continue to enhance our SmartChip genomics analysis solution with additional gene panel offerings," said Alnoor Shivji, Chairman and CEO.  "Our custom panels with quick turnaround time will enable researchers to conduct large-scale validation studies with unmatched speed and cost advantages.  We now offer the ability to run up to 384 samples on a single SmartChip, offering the maximum flexibility to researchers involved in biomarker validation studies. Combined with our growing breadth of validated gene expression assays, the SmartChip Custom Panels contribute to the SmartChip System becoming an industry-leading
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. WaferGen Names Gary P. Schroth, Ph.D., as New SVP, Genomics Research and Applications
2. WaferGen Corporate Presentation to be Webcast at Rodman and Renshaws 12th Annual Healthcare Conference
3. WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System
4. WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip(TM) Nano-Dispenser with WaferGens SmartChip(TM) High-throughput Real-Time PCR System
5. WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Companys Scientific Advisory Board
6. WaferGen Closes on Private Financings of Approx. $6.2 Million
7. WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference
8. Data on WaferGens SmartChip(TM) System to be Presented at 3rd Annual Rediscovering Biomarkers Conference
9. WaferGen Announces Signing of Private Financing
10. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
11. WaferGen to Present Data on SmartChip(TM) Real-Time PCR System at Cambridge Healthtech Institutes Quantitative PCR Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... PA & Boston, MA (PRWEB) July 28, 2014 ... collaboration agreements with two researchers to further develop potential ... deadly malignant brain tumor, in combination with their patented ... by ITI and Duke University, are based on the ... Chief, Division of Neurosurgery at The Preston Robert Tisch ...
(Date:7/28/2014)... , July 28, 2014  InterMune, Inc. (NASDAQ: ... release its second quarter 2014 financial results at the ... 2014. A live conference call and webcast will be hosted ... day. Interested investors and others may participate ... +1 212-231-2900 (international), conference ID#21728775. A replay of the webcast ...
(Date:7/25/2014)... "Ischemic Stroke and Cerebral Stroke ... on the Ischemic Stroke and Cerebral Stroke clinical ... data relating to the clinical trials on Ischemic ... Ischemic Stroke Research Report 2014 at: http://www.marketresearchreports.biz/analysis/213207 ... trial numbers and their recruitment status as per ...
(Date:7/25/2014)... According to a new market report ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... estimated at USD 161,056.5 million in 2014 and is ... 2014 to 2020, to reach an estimated value of ... market is witnessing a significant growth due to the ...
Breaking Biology Technology:String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4InterMune to Release Second Quarter Financial Results on August 6 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3
... 5 Cell Therapeutics (CTI),(Nasdaq and MTA: CTIC) announced ... Preferred Stock in exchange for 6,634 shares of CTI,s ... constitutes 83% in interest of all,series of CTI,s Convertible ... become convertible into 7,143 shares of CTI,s common stock, ...
... DIEGO, Feb. 4 Orexigen(R) Therapeutics, Inc.,(Nasdaq: OREX ), ... the Company will be speaking at the 11th Annual,BIO CEO & ... Corporate Presentation:, Date: Monday, February 9, ... Eastern, Location: Waldorf Astoria, Astor Room, New York, ...
... Feb. 4 NeurogesX, Inc. (Nasdaq: NGSX ... novel pain management therapies, announced today that Anthony DiTonno, ... at the 11th Annual BIO CEO & Investor Conference ... Mr. DiTonno and Stephen Ghiglieri, Chief Financial Officer, will ...
Cached Biology Technology:Cell Therapeutics Exchanges 83% of Remaining Convertible Preferred Stock Into New Non-dividend Bearing, Non-redeemable Convertible Preferred Stock With Conversion Price of $0.14 per Share 2NeurogesX to Present at 11th Annual BIO CEO & Investor Conference 2NeurogesX to Present at 11th Annual BIO CEO & Investor Conference 3
(Date:7/28/2014)... top 10 U.S. cities that have seen an increase ... frequent road closures, overwhelmed storm drains and compromised infrastructure--are ... technical report. , This nuisance flooding, caused by rising ... between 300 and 925 percent since the 1960s. , ... Changes around the United States, also finds Annapolis and ...
(Date:7/28/2014)... The findings of a new study suggest two ways ... not work as well in obese women, compared to women ... are a one-size-fits-all method, researchers say, but as the population ... the pill works for obese women. Studies have consistently found ... the body, which may in turn affect how well the ...
(Date:7/28/2014)... He calls himself the bug hunter, but the ... only be found and identified with special methods and ... Kansas State Veterinary Diagnostic Laboratory at Kansas State University, ... porcine enterovirus G, which is an important find in ... in cells, but didn,t know what it was," Hause ...
Breaking Biology News(10 mins):NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Strategies identified to improve oral contraceptive success with obese women 2Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3
... Kan. -- With harvest in full swing, many farmers have ... and minimal rainfall has left most wheat yields looking less ... ugly. But as a Kansas State University plant pathologist ... also has been battling a much smaller opponent: viruses. ...
... to be an acclaimed field biologist and college dean is ... Joseph Travis, dean of the College of Arts and Sciences ... researcher in the field of ecological genetics, has won the ... of the ASN in June, the award "is given to ...
... 2011 , the New York Academy of Sciences will ... of subspecialties, in addition to patients and caregivers, to ... of the clinical features, management, and treatment of Shwachman-Diamond ... affecting children and young adults. The clinical features ...
Cached Biology News:Plant pathologist finding Kansas wheat fields a molecular battleground this season 2FSU dean wins prestigious E.O. Wilson Naturalist Award 2FSU dean wins prestigious E.O. Wilson Naturalist Award 3New York Academy of Sciences hosts a conference on rare disease Shwachman-Diamond Syndrome 2
...
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
Normal human AB serum, pooled...
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Biology Products: